Par Health Issues Voluntary Nationwide Recall Of Two Lots Of Brevital® Sodium 500 Mg/vial Civ (methohexital Sodium For Injection, Usp) Due To The Presence Of Particulate Matter
- Recalling firm
- Par Health
- Product
- Two Lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium
- Reason
- FOR IMMEDIATE RELEASE - ROCHESTER, MI– October 8, 2026 –Par Health is voluntarily recalling two lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) to the hospital level. The product is being recalled due to the presence of particulate matter identified as cellulose.
- Category
- drug recall
- Country
- United States
- Agency
- FDA-MEDWATCH-RSS
- Recall date
- 2026-10-09
- Status
- Ongoing
Official recall notice from FDA-MEDWATCH-RSS
Recall details on Nibble Recalls: https://trynibble.app/recalls/6de8e8a2-280a-41a1-97c7-97bd480b5b66